A case of bullous pemphigoid nduced by vildagliptin
CUTANEOUS AND OCULAR TOXICOLOGY, vol.36, no.2, pp.201-202, 2017 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 36 Issue: 2
- Publication Date: 2017
- Doi Number: 10.1080/15569527.2016.1211670
- Journal Name: CUTANEOUS AND OCULAR TOXICOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.201-202
- Hacettepe University Affiliated: Yes
Abstract
Bullous pemfigoid (BP), an autoimmune disorder, can also be induced by some medications. Vildagliptin is a new drug used to treat diabetes mellitus (DM). Recently, a few cases of vildagliptin-induced BP have been described in the literature. We report a patient with BP in which vildagliptin was thought to be as a possible causative agent. The awareness of BP development risk during gliptin therapy can prevent unnecessary usage of systemic drugs with serious side effects.